ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.176,39
0,55%
S&P 500
5.187,69
0,13%
US Dollar vs BRL
5,0669
-0,19%
Bitcoin
63.020,65
-0,23%
Brent Oil
83,095
-0,46%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sienna Biopharmaceuticals Inc (SNNA)

  7. Sienna Biopharmaceuticals Inc (SNNA) Notícias

SNNA

Sienna Biopharmaceuticals (SNNA)

Sienna Biopharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNNA
DataHoraFonteTítuloCódigoCompanhia
07/02/202013:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNNASienna Biopharmaceuticals Inc
05/02/202012:47Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:SNNASienna Biopharmaceuticals Inc
09/01/202010:00PR Newswire (US)Sebacia Announces Leadership Update and Acquisition of Silver Photoparticle Technology Assets from Sienna BiopharmaceuticalsNASDAQ:SNNASienna Biopharmaceuticals Inc
17/12/201908:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201918:46Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201918:40Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201918:36Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/12/201908:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNNASienna Biopharmaceuticals Inc
14/11/201918:05GlobeNewswire Inc.Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding ProceduresNASDAQ:SNNASienna Biopharmaceuticals Inc
14/11/201910:30GlobeNewswire Inc.Sienna Biopharmaceuticals Announces Successful Appeal of Nasdaq Delisting NoticeNASDAQ:SNNASienna Biopharmaceuticals Inc
12/11/201918:42Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNNASienna Biopharmaceuticals Inc
07/10/201909:30GlobeNewswire Inc.Sienna Biopharmaceuticals Files 510(k) Submission with FDA for SNA-001, its Novel Silver Photoparticle Technology to Remove L...NASDAQ:SNNASienna Biopharmaceuticals Inc
04/10/201915:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNNASienna Biopharmaceuticals Inc
17/09/201909:30GlobeNewswire Inc.Sienna Biopharmaceuticals Initiates Voluntary Chapter 11 Protection ProceedingNASDAQ:SNNASienna Biopharmaceuticals Inc
05/08/201910:05GlobeNewswire Inc.Sienna Biopharmaceuticals Engages Cowen to Explore Financial and Strategic AlternativesNASDAQ:SNNASienna Biopharmaceuticals Inc
20/06/201910:05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare ConferenceNASDAQ:SNNASienna Biopharmaceuticals Inc
10/06/201910:05GlobeNewswire Inc.Sienna Biopharmaceuticals Announces Late-Breaking Oral Presentation of Phase 2b Trial Results of its Topical, Non-Steroidal T...NASDAQ:SNNASienna Biopharmaceuticals Inc
21/05/201910:05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at Dermatology Drug Development Summit EuropeNASDAQ:SNNASienna Biopharmaceuticals Inc
14/05/201910:05GlobeNewswire Inc.Sienna Biopharmaceuticals Announces SNA-120 (0.05%) Biopsy Data Demonstrate Positive Impact on Key Inflammatory Cytokines, in...NASDAQ:SNNASienna Biopharmaceuticals Inc
09/05/201910:05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at BAML Health Care ConferenceNASDAQ:SNNASienna Biopharmaceuticals Inc
08/05/201917:05GlobeNewswire Inc.Sienna Biopharmaceuticals Reports First Quarter 2019 Financial ResultsNASDAQ:SNNASienna Biopharmaceuticals Inc
11/04/201909:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNNASienna Biopharmaceuticals Inc
11/04/201909:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNNASienna Biopharmaceuticals Inc
03/04/201918:25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNNASienna Biopharmaceuticals Inc
21/03/201917:05GlobeNewswire Inc.Sienna Biopharmaceuticals Promotes Alexander Azoy to Chief Financial Officer and Appoints Sean Andrews to Leadership Team as ...NASDAQ:SNNASienna Biopharmaceuticals Inc
14/03/201910:19Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNNASienna Biopharmaceuticals Inc
14/03/201910:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNNASienna Biopharmaceuticals Inc
14/03/201910:05GlobeNewswire Inc.Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial ResultsNASDAQ:SNNASienna Biopharmaceuticals Inc
06/03/201918:41Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:SNNASienna Biopharmaceuticals Inc
05/03/201911:05GlobeNewswire Inc.Sienna Biopharmaceuticals to Present at Cowen and Company Health Care ConferenceNASDAQ:SNNASienna Biopharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNNA

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
NGRD3
Neogrid Participacoes ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
AZEV4
AZEVEDO PN
BOV
IRBR3
IRB BRASIL ON
BOV
HAGA3
HAGA ON
BOV
OIBR3
OI ON
BOV
PRIO3
PETRORIO ON
BOV
BRKM5
BRASKEM PNA
BOV
TELB4
TELEBRAS PN
BOV
TPIS3
TRIUNFO PART ON
BOV
GOLL4
GOL PN
BOV
MNPR3
MINUPAR ON
BOV
ETER3
ETERNIT ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados